NCT01755949 - Colchicine and CRP in Atrial Fibrillation and AF Ablation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

December 6, 2016

Study Completion Date

December 6, 2016

Conditions

Atrial Fibrillation

Interventions

DRUG

Colchicine, 0.6 mg PO BID

Colchicine tablets will be over-encapsulated by the research pharmacy to be indistinguishable from placebo

DRUG

Matching placebo

Matching placebo tablets will be encapsulated by the research pharmacy to be indistinguishable from active drug

Trial Locations (1)

Mayo Clinic Florida, Jacksonville